PET/MR in prostate cancer: technical aspects and potential diagnostic value. - Wikidata - awgldk - TriplyDB

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

http://www.wikidata.org/entity/Q38109083

about

Positron emission tomography-magnetic resonance imaging: technical review.Update on positron emission tomography for imaging of prostate cancer Quality control for quantitative multicenter whole-body PET/MR studies: A NEMA image quality phantom study with three current PET/MR systems.Update on advances in molecular PET in urological oncology Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.Current use of PSMA-PET in prostate cancer management.68 Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment.Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer.Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors.MR-guided attenuation map for prostate PET-MRI: an intensity and morphologic-based segmentation approach for generating a five-class attenuation map in pelvic region.The use of PET/CT in prostate cancer.A novel alternative to classify tissues from T 1 and T 2 relaxation times for prostate MRI.Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging.Impact of 68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer.[PET-CT and PET-MRI of the prostate : From 18F-FDG to 68Ga-PSMA].Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.PET/MRI and prostate cancer Prostate cancer imaging

P2860

Q26998059-3CB721BB-C22A-4E34-8E10-87EED402F339 Q27026828-CB69345C-4D76-42D3-8516-32EAB3D02C3D Q31000575-CB0330AC-1668-4B35-96ED-67B5F913572F Q33625389-A05ABFA1-7C0F-4F77-BB1E-94C89C34EFB7 Q38321182-E1E59448-C17D-443D-9C64-A94043020028 Q38411032-B04BE3AF-1E84-4B23-AE8C-AA87FB75FEF5 Q38744524-C3E5C374-B66B-4588-A9BB-B8B994241E5C Q38895102-B3BC5A6B-A4B1-4CCE-B0E7-09DD1A88E20E Q39690658-CD2F5E0C-D2ED-47D5-B80E-F615864147F2 Q47399023-F38C09EE-F2DA-4CFE-989D-0B6DF960A962 Q48677167-8AF72211-815B-4D44-8B67-0726342F25E8 Q49919217-959D1252-647A-4116-BC6D-AAA91A1AF4EE Q50650029-49A1CA5B-A9D7-4D69-91AA-C93326B79891 Q51840218-78BF0642-8099-4D94-87E9-FD4AB87FB1BA Q52680980-D46789C4-AF3F-440F-ADD2-0989FB6D5C28 Q52938281-6582A528-D5FE-436B-9E03-E7AFC3771925 Q52982825-0EB80CBB-F26A-4CB8-A4B7-41EEAEC63950 Q57780524-985407E6-0ADB-454C-BCF1-A92176FBF97D Q57780548-3C983C1C-E8A6-41C0-8D25-BADA738C0DD6

P2860

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

http://www.wikidata.org/entity/Q38109083

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

@en

type

label

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

@en

prefLabel

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

@en

P1433

Q38109083-543DBEFC-CA7B-4232-A51C-95F615F52B39

P1476

Q38109083-E3B03BC0-2DBF-47B0-B1ED-CF0C33C1CCF8

P2093

Q38109083-1E1B8EF4-264A-4170-A2FE-C6CF3BE47293

Q38109083-20F54A61-DEE3-471F-8908-1A854EBF4B01

Q38109083-756B0138-04D3-46CA-8F66-B96AF580572A

Q38109083-7EDE9522-FE7D-4211-BD69-7ADE3ABAB128

Q38109083-A2599B25-BB28-47C2-A245-FB4928266E62

Q38109083-AA73932A-74E3-4B9A-8951-41186205D6A3

Q38109083-C24B8D93-C23B-4B6D-AEF5-8910C41731C5

Q38109083-F6E2E39A-6AB0-4A46-BA31-4BC7CEBE2FDA

P2860

Q38109083-0B5E56F0-4721-4552-9515-81A0BB04CC07

Q38109083-177E7B13-746E-4E5F-9847-4D22B3A6AD57

Q38109083-21042685-D7A0-46EA-B6CC-486074FEA91B

Q38109083-2245CDDB-1867-41F0-8F7A-1ED9443AB44C

Q38109083-32F1F7D3-ACB2-49FA-8EC3-0B8CC2232F28

Q38109083-4049CCB1-4389-4352-9E01-106D6D90E4D0

Q38109083-43792311-3350-4E05-AC21-0EC747A66F3C

Q38109083-441DD94F-997D-4167-894F-10ADBE36EB62

Q38109083-44FF9A63-82A7-42BD-AF13-41CCDA4BD7C9

Q38109083-473A8FE0-1687-476E-82D2-05E9974BA1F4

P2888

Q38109083-47E38AE9-815F-41B9-8F5E-664BECAA7493

P304

Q38109083-C2CC7D16-52E0-474F-99FF-28C62DFA663A

P31

Q38109083-B27432A2-B866-4D50-98ED-A649E2F5624E

P356

Q38109083-03874511-AD3A-47E4-8AAC-7CC4FE071765

P478

Q38109083-39730F66-BFB3-4617-8B68-4EFF11C70C4A

P50

Q38109083-C4C2881C-9EA3-41DE-A981-8540CB9EBE97

Q38109083-F0F61FDF-8026-4803-AFF2-5E310648CCB8

P577

Q38109083-9334DFF3-A962-4761-9808-A85779F8943A

P698

Q38109083-9AC53B0F-60AB-4082-9CA5-3D7CC336C3E8

P356

S00259-013-2445-4

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

@en

P2093

Ambros J Beer

http://www.w3.org/2001/XMLSchema#string

Axel Martinez-Moeller

http://www.w3.org/2001/XMLSchema#string

Konstantin Holzapfel

http://www.w3.org/2001/XMLSchema#string

Matthias Eiber

http://www.w3.org/2001/XMLSchema#string

Michael Souvatzoglou

http://www.w3.org/2001/XMLSchema#string

Sebastian Fürst

http://www.w3.org/2001/XMLSchema#string

Sibylle Ziegler

http://www.w3.org/2001/XMLSchema#string

Stephan Nekolla

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.

An integrated MR/PET system: prospective applications.

Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.

Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data.

Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system.

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods.

Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology.

Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects.

P2888

s00259-013-2445-4

P304

S79-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-013-2445-4

http://www.w3.org/2001/XMLSchema#string

P478

40 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Markus Schwaiger

P577

2013-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23703457

http://www.w3.org/2001/XMLSchema#string